Omission of ALND in Breast Cancer Patients With Axillary pCR

NARecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 11, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions
Axillary Lymph Node DissectionPathological Complete ResponseNeoadjuvant Systemic TherapyBreast CancerAxillary Lymph
Interventions
PROCEDURE

Stained region Lymph Node Biopsy (SrLNB)

Before NST, carbon nanoparticles suspension would be injected into the cortex of positive lymph nodes for staining under ultrasound guidance. Marked lymph nodes will be removed and biopsied after NST.

RADIATION

Regional lymph node radiotherapy (RNI) including the axilla

RNI including the axilla covers the supraclavicular region and entire axillary lymphatic drainage area (region I, II and III) ,and is at a dose of 50 Gy/25 times, with additional prophylactic irradiation of the internal breast lymphatic drainage area for eligible patients.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER